Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Disorders of the Female Reproductive System01:24

Disorders of the Female Reproductive System

4.7K
The female reproductive system can be affected by several disorders, including Premenstrual Syndrome (PMS), Premenstrual Dysphoric Disorder (PMDD), endometriosis, and various forms of cancer. PMS and PMDD are cyclical conditions that cause physical and emotional distress, with symptoms that include edema, mood swings, and food cravings. PMDD is a more severe form of PMS characterized by increased symptom severity that peaks during the luteal phase and tends to improve or resolve shortly after...
4.7K
Mitral Valve Prolapse III: Nursing Management01:19

Mitral Valve Prolapse III: Nursing Management

505
The nursing management of Mitral Valve Prolapse, or MVP, centers around patient education, symptom monitoring, and lifestyle modifications.Patient Education on MVP Diagnosis and Heredity: Nurses should provide comprehensive education about MVP, a condition where the mitral valve does not close appropriately during heartbeats. This education often includes the condition's pathophysiology, symptoms, and potential complications, like arrhythmias or mitral regurgitation. Though not fully...
505
Teratogenicity01:07

Teratogenicity

4.4K
The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...
4.4K
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

1.4K
Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...
1.4K
Pulmonary Embolism I: Introduction01:29

Pulmonary Embolism I: Introduction

1.1K
Pulmonary embolism (PE) occurs when a thrombus, fat or air embolus, amniotic fluid, or tumor tissue blocks one or more pulmonary arteries. These blockages originate in the venous system or the right side of the heart.EtiologyPE primarily arises from deep vein thrombosis (DVT) and other hypercoagulable states, such as inherited thrombophilias. Additional etiological factors include venous stasis, commonly seen in obesity, and endothelial injury from surgery and trauma. Less common causes include...
1.1K
Cardiomyopathy I: Introduction and Classification01:25

Cardiomyopathy I: Introduction and Classification

749
Cardiomyopathy, or CMP, is a group of diseases affecting the myocardial structure, impairing its ability to pump blood effectively. This condition can lead to arrhythmias, heart failure, or sudden cardiac death.Cardiomyopathies are classified into primary and secondary categories:Primary Cardiomyopathy refers to conditions involving only the heart muscle that are often idiopathic (of unknown cause) or genetic. They primarily affect the myocardium without the involvement of other systemic...
749

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Longitudinal Serum Metabolomic Signatures Related to Integrase Strand Transfer Inhibitors-Associated Weight Gain in Women with HIV Enrolled in the MACS/WIHS Combined Cohort Study.

The Journal of infectious diseases·2026
Same author

Anxiety Among Perinatal Women Living With HIV: A Global Scoping Review.

The Journal of the Association of Nurses in AIDS Care : JANAC·2026
Same author

Identifying Core Competencies for Occupational and Environmental Health Nurse Practitioners: An Integrative Review.

Workplace health & safety·2026
Same author

Anticipatory grief among caregivers of people living with dementia: A scoping review.

Palliative & supportive care·2026
Same author

Anxiety trajectories in cancer patients during active treatments: Clusters, influencing factors, and impact on quality of life and health service utilization.

Journal of affective disorders·2026
Same author

Reimagining Perinatal Care in Alabama Through Innovative Partnerships.

Journal of midwifery & women's health·2026

Related Experiment Video

Updated: Mar 16, 2026

External Cephalic Version: Is it an Effective and Safe Procedure?
08:49

External Cephalic Version: Is it an Effective and Safe Procedure?

Published on: June 6, 2020

16.0K

Seeking a Universal Definition for Severe Maternal Morbidity.

Tina Smith, Julie Schexnayder, Hsiao-Lan Wang

    Journal of Obstetric, Gynecologic, and Neonatal Nursing : JOGNN
    |March 14, 2026
    PubMed
    Summary

    Severe maternal morbidity (SMM) poses life-threatening risks during pregnancy. This commentary reviews current SMM definitions and proposes a standardized term to improve accurate incidence measurement and maternal outcomes.

    Keywords:
    adverse birth outcomesmaternal healthmaternal mortalityobstetric labor complicationspregnancy complicationssevere maternal morbidity

    More Related Videos

    Modeling Ascending Vaginal Infection, Preterm Birth, and Neonatal Morbidity in Mice
    04:18

    Modeling Ascending Vaginal Infection, Preterm Birth, and Neonatal Morbidity in Mice

    Published on: October 10, 2025

    637
    A Murine Model of Group B Streptococcus Vaginal Colonization
    10:19

    A Murine Model of Group B Streptococcus Vaginal Colonization

    Published on: November 16, 2016

    15.2K

    Related Experiment Videos

    Last Updated: Mar 16, 2026

    External Cephalic Version: Is it an Effective and Safe Procedure?
    08:49

    External Cephalic Version: Is it an Effective and Safe Procedure?

    Published on: June 6, 2020

    16.0K
    Modeling Ascending Vaginal Infection, Preterm Birth, and Neonatal Morbidity in Mice
    04:18

    Modeling Ascending Vaginal Infection, Preterm Birth, and Neonatal Morbidity in Mice

    Published on: October 10, 2025

    637
    A Murine Model of Group B Streptococcus Vaginal Colonization
    10:19

    A Murine Model of Group B Streptococcus Vaginal Colonization

    Published on: November 16, 2016

    15.2K

    Area of Science:

    • Obstetrics and Gynecology
    • Public Health
    • Maternal Health

    Background:

    • Pregnancy complications, termed severe maternal morbidity (SMM), present significant risks to maternal and infant health.
    • The United States experiences higher rates of SMM and maternal mortality compared to other high-income nations.
    • Accurate identification of SMM is crucial for improving maternal and perinatal outcomes.

    Purpose of the Study:

    • To review existing definitions of severe maternal morbidity (SMM) in medical literature.
    • To propose an integrative and potentially universal definition for SMM.
    • To address the lack of a standardized definition hindering accurate incidence measurement.

    Main Methods:

    • Literature review of current severe maternal morbidity definitions.
    • Analysis of inconsistencies in SMM terminology.
    • Development of a proposed integrative definition for SMM.

    Main Results:

    • Current literature lacks a consistent definition for severe maternal morbidity (SMM).
    • This inconsistency impedes accurate measurement of SMM incidence.
    • A standardized definition is essential for effective SMM identification and management.

    Conclusions:

    • A universally accepted definition for severe maternal morbidity (SMM) is needed.
    • Standardizing the definition of SMM will facilitate better data collection and analysis.
    • An integrative definition can enhance efforts to reduce SMM and improve maternal health outcomes.